Overview

Intranasal Fentanyl for Pain Management

Status:
Unknown status
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Goal of the research will be to demonstrate a reduction in reported pain following the atomization and intra-nasal administration of Fentanyl versus the reduction in pain achieved from intravenous Fentanyl. It is hypothesized that pain should be reduced following fentanyl administration using the intra-nasal atomization equal to the intravenous delivery.
Phase:
Phase 4
Details
Lead Sponsor:
Genesys
Treatments:
Fentanyl